NCT04663555 Effect of Two Different Doses of Dexamethasone in Patients With ARDS and COVID-19 Status COMPLETED Phase PHASE4
NCT04661137 A Study of Selinexor, in Combination With Carfilzomib, Daratumumab or Pomalidomide in Patients With Multiple Myeloma Status SUSPENDED Phase PHASE2
NCT04653246 Isatuximab, Lenalidomide, Bortezomib, and Dexamethasone in NDMM Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT04649060 Study of Melflufen (Melphalan Flufenamide) in Combination With Daratumumab in Relapsed-Refractory Multiple Myeloma Status TERMINATED Phase PHASE3
NCT04643002 Isatuximab in Combination With Novel Agents in RRMM - Master Protocol Status RECRUITING Phase PHASE1/PHASE2
NCT04638790 First Line Chemotherapy for Classical Hodgkin Lymphoma in Russia (HL-Russia-1) Status RECRUITING Phase PHASE3
NCT04636671 Methylprednisolone vs. Dexamethasone in COVID-19 Pneumonia (MEDEAS RCT) Status COMPLETED Phase PHASE3
NCT04635189 Steroid Sparing Treatment With in Newly Diagnosed Transplant Ineligible Patients With Multiple Myeloma Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT04633850 Implementation of Adjuvants in Intercostal Nerve Blockades for Thoracoscopic Surgery in Pulmonary Cancer Patients Status COMPLETED Phase N/A
NCT04624360 The Effect of IV Dexamethasone on the Duration of Analgesia of Spinal Anaesthesia for C-Sections at a Jamaican Hospital Status UNKNOWN Phase PHASE4
NCT04606264 Recommendations of Enhanced Recovery Interventions for Patient's Clinical Team and Collection of Associated Data Status COMPLETED Phase PHASE3
NCT04588857 Efficacy of a Single Dose Dexamethasone in Reducing the Postembolization Syndrome in Men Undergoing Prostatic Artery Embolization for Benign Prostatic Hyperplasia Status UNKNOWN Phase PHASE4
NCT04588194 Romiplostim, Rituximab and Dexamethasone as Frontline Treatment for Immune Thrombocytopenia Status UNKNOWN Phase PHASE2
NCT04580121 A Dose Escalation and Expansion Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7283420. Status COMPLETED Phase PHASE1
NCT04570631 Study to Determine Recommended Phase 2 Dose of Intravenous (IV) Eftozanermin Alfa in Combination With IV or Subcutaneous (SC) Bortezomib and Oral Dexamethasone Tablet and to Assess Change in Disease Symptoms in Adult Participants With Relapsed or Refractory Multiple Myeloma Status TERMINATED Phase PHASE1
NCT04566328 Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial Status RECRUITING Phase PHASE3
NCT04563494 The Effects of IV vs Oral Dexamethasone on Postoperative Nausea, Vomiting, and Pain Status COMPLETED Phase PHASE4